BOM/532296 (BOM/532296)

Bombay Stock Exchange: BOM/532296 · INR

₹2,300

+31.45 (+1.4%)· Recorded snapshot

Market cap	648.2B
Revenue (ttm)	177.4B
Net income (ttm)	18B
EPS (ttm)	₹63.7
P/E (trailing)	36.1x
P/E (forward)	26.5x
Dividend	₹2.50 (0.11%)
Volume	16,530

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 177.4B
Net income (ttm): 18B
EPS (ttm): ₹63.7
P/E (trailing): 36.1x
P/E (forward): 26.5x
Market cap: 648.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E26.5

P25 n/aP50 n/aP75 n/a

Trailing P/E36.1

P25 n/aP50 n/aP75 n/a

ROE14.1

P25 n/aP50 n/aP75 n/a

ROIC29.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/532296 indicators

Market & fundamental data

Available fields

245

Groups with data

Currency

INR

Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-05
Employees	16,946
Employees change	1,146
Employees growth	7.25%
Enterprise value	INR 642.4B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1977
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	INE935A01035
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Last stock split date	2007-09-10
Last stock split type	Forward
Market cap	INR 648.2B
Next earnings date	2026-11-05
Price	INR 2,300.35
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bom/532296
Website	https://glenmarkpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.66x
Average P/E ratio (5Y)	35.36x
Earnings yield	2.77%
EV/Earnings	35.24x
EV/EBIT	15.16x
EV/EBITDA	13.11x
EV/FCF	30.35x
EV/Sales	3.57x
FCF / EV yield	3.29%
FCF yield	3.26%
Forward P/E	26.48x
Graham number	731.75821
Graham upside	-67.75%
Industry forward P/E	33.08x
Industry P/E	38.9x
Lynch fair value	INR 762.25
Lynch upside	-66.4%
P/(FCF - SBC) ratio	31.03x
P/(OCF - SBC) ratio	18.71x
P/B ratio	6.08x
P/E ratio	36.12x
P/FCF ratio	30.63x
P/OCF ratio	18.56x
P/S ratio	3.6x
Price / tangible book value	7.99x
Price/EBITDA ratio	13.23x
Sector forward P/E	36.12x
Sector P/E	45.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	23.57%
EBITDA margin	27.24%
Effective tax rate	29.01%
FCF margin	12.25%
Gross margin	71.94%
Operating margin	23.57%
Pretax margin	14.28%
Profit margin	10.14%
Profit per employee	INR 1.1M
Profitable quarters	9
Profitable years	2
Revenue per employee	INR 10.5M
ROA	14.11%
ROA (5Y)	7.65%
ROCE	30%
ROE	14.07%
ROE (5Y)	3.4%
ROIC	29.9%
ROIC (5Y)	-129.61%
SBC / revenue	0.16%
Tax / revenue	4.14%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	138.55%
EPS growth (Q)	930.72%
EPS growth (QoQ)	60.25%
EPS growth 10Y	9.45%
EPS growth 3Y	91.85%
EPS growth 5Y	11.94%
EPS growth quarters	4
EPS growth years	2
FCF growth 3Y	391.04%
FCF growth 5Y	42.4%
Gross profit growth	40.47%
Gross profit growth (Q)	23.29%
Gross profit growth 3Y	12.92%
Gross profit growth 5Y	10.96%
Net income growth	138.54%
Net income growth (Q)	930.33%
Net income growth (QoQ)	60.22%
Net income growth 3Y	91.84%
Net income growth 5Y	11.95%
Net income growth quarters	4
Net income growth years	2
OCF growth 10Y	25.88%
OCF growth 3Y	76.61%
OCF growth 5Y	24.95%
Operating income growth	126.49%
Operating income growth (Q)	40.18%
Operating income growth 3Y	31.01%
Operating income growth 5Y	18.53%
Revenue growth	32.94%
Revenue growth (Q)	23.1%
Revenue growth (QoQ)	4.9%
Revenue growth 10Y	8.5%
Revenue growth 3Y	9.22%
Revenue growth 5Y	8.84%
Revenue growth quarters	5
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -13.6B
Depreciation and amortization	INR 6.5B
EBIT	INR 41.8B
EBITDA	INR 48.3B
EPS	INR 63.69
Financing cash flow	INR -27.1B
Free cash flow	INR 20.9B
Free cash flow minus SBC	INR 20.6B
Gross profit	INR 127.6B
Income taxes	INR 7.3B
Investing cash flow	INR -12.8B
Net borrowing	INR -23.6B
Net cash flow	INR -5B
Net income	INR 18B
Operating cash flow minus SBC	INR 34.2B
Operating income	INR 41.8B
Revenue	INR 177.4B
Stock-based compensation	INR 268.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 372.48
Debt / EBITDA	0.12
Debt / equity	0.06
Debt / FCF	0.28
Interest coverage	20.44
Net cash (debt)	INR 5.8B
Net cash / market cap	0.91%
Net debt / EBITDA	-0.12
Net debt / equity	-0.06
Net debt / FCF	-0.28
Piotroski F-Score	7
Shareholders' equity	INR 105.1B
Tangible book value	INR 80.1B
Tangible book value per share	INR 283.67
Total cash	INR 11.8B
Total debt	INR 5.9B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.95
Current ratio	1.77
Inventory turnover	1.53
Quick ratio	1.11
Working capital	INR 49.2B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0%
Dividend growth	-50%
Dividend growth (10Y)	2.26%
Dividend growth (3Y)	0%
Dividend growth (5Y)	0%
Dividend growth years	1
Dividend payment date	2026-10-11
Dividend payment years	18
Dividend payout frequency	Semi-Annual
Dividend per share	INR 2.50
Dividend yield	0.11%
Ex-dividend date	2026-08-31
Last dividend	INR 2.50
Payout ratio	3.93%
Shareholder yield	0.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	150.32%
10Y return CAGR	10%
10Y total return	159.42%
150-day SMA	INR 2,277.59
15Y price change	644.02%
15Y return CAGR	14.71%
15Y total return	683.94%
1D price change	1.39%
1M price change	-4.79%
1M total return	-4.79%
1W price change	2.72%
1W total return	2.72%
1Y price change	25.21%
1Y return CAGR	25.35%
1Y total return	25.33%
20-day SMA	INR 2,259.61
200-day SMA	INR 2,219.99
20Y price change	1,023.77%
20Y return CAGR	13.2%
20Y total return	1,094.08%
3M price change	3.39%
3M total return	3.5%
3Y price change	205.06%
3Y return CAGR	45.26%
3Y total return	206.55%
50-day SMA	INR 2,350.70
50-day SMA vs 200-day SMA	50over200
52-week high	INR 2,536.85
52-week high date	2026-08-28
52-week low	INR 1,794.00
52-week low date	2025-10-28
5Y price change	350.4%
5Y return CAGR	35.51%
5Y total return	356.87%
6M price change	-2.41%
6M total return	-2.31%
All-time high	INR 2,536.85
All-time high date	2026-08-28
All-time low	INR 1.89
All-time low date	2000-02-10
Average true range (ATR)	INR 68.03
Average volume	18.9K
Change from 52-week high	-9.32%
Change from 52-week low	28.23%
Change from all-time high	-10.56%
Change from all-time low	119,947.62%
Change from open	1.8%
Day's gap	-0.41%
Dollar volume	INR 38M
High price	INR 2,318.30
Low price	INR 2,259.65
Monthly RSI	63.25
Open price	INR 2,259.65
Position in 52-week range	69.39%
Previous close	INR 2,268.90
Price vs 150-day SMA	-0.38%
Price vs 20-day SMA	0.41%
Price vs 200-day SMA	2.2%
Price vs 50-day SMA	-3.48%
Relative volume	0.88
RSI	52.05
Sharpe ratio	0.78
Sharpe ratio (3Y)	1.2
Sharpe ratio (5Y)	1.02
Sortino ratio	1.34
Sortino ratio (3Y)	2.12
Sortino ratio (5Y)	1.8
Volume	16.5K
Weekly RSI	52.61
YTD price change	11.45%
YTD total return	11.56%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	150.2M
Shares change (QoQ)	0.01%
Shares change (YoY)	-0%
Shares held by insiders	1.24%
Shares held by institutions	29.45%

Deeper analysis on BOM/532296

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/532296 report

Is a complete BOM/532296 research report available?

No complete published report is available for bom/532296 (BOM/532296) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/532296 (BOM/532296)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/532296

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/532296 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/532296

Frequently asked questions